Last $6.72 USD
Change Today +0.32 / 5.00%
Volume 464.8K
XNPT On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark A. Gallop Ph.D.

Co-Founder, Xenoport, Inc.
AgeTotal Calculated CompensationThis person is connected to 26 board members in 2 different organizations across 4 different industries.

See Board Relationships
51--

Background*

Dr. Mark A. Gallop, Ph.D., co-founded Xenoport Inc., in 1999. and served as its Senior Vice President of Research from January 2004 to 2010. Dr. Gallop served as Vice President of Chemistry at Xenoport Inc from 1999 to 2004. He serves as Member of Scientific Advisory Board at Protagonist Pty Ltd. He serves as Member of Scientific Advisory Board at Envoy Therapeutics, Inc. Dr. Gallop held several positions at Affymax Research Institute, which was senior director of combinatorial ...

Read Full Background

Corporate Headquarters*

3410 Central Expressway
Santa Clara, California 95051

United States

Phone: 408-616-7200
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
University of Cambridge
BS
The University of Auckland
Master's Degree
The University of Auckland

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
XNPT:US $6.72 USD +0.32

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael S. Anderson Chief Executive Officer and Director
Flamel Technologies SA
--
Scott Schorer Chief Executive Officer
PlasmaTech Biopharmaceuticals, Inc.
--
James A. Schoeneck Chief Executive Officer, President and Director
DepoMed Inc.
$590.6K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
Compensation as of Fiscal Year --.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact XENOPORT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.